Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Vigonvita Life Sciences (VVL HK)
Watchlist
11
Analysis
Health Care
•
China
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Alibaba
•
11 Aug 2025 08:08
ECM Weekly (11 August 2025)-Bharti, Eternal, Paytm, LG CNS, Guming, JSW, Bluestone, SICC, Roborock
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
Sumeet Singh
Follow
831 Views
Share
bearish
•
Vigonvita Life Sciences
•
05 Aug 2025 15:26
Vigonvita Life Sciences (旺山旺水) Pre-IPO: Structural Challenges for Commercialization
Vigonvita seeks to raise $100 million in Hong Kong IPO with CITIC as book runner. We look at changes in the company's assets and progresses. We...
Ke Yan, CFA, FRM
Follow
474 Views
Share
bullish
•
Vigonvita Life Sciences
•
29 May 2025 08:55
Pre-IPO Vigonvita Life Sciences - The Challenges Behind the Pipeline and the Outlook
Vigonvita's valuation hinges on innovative drug pipeline but excluding COVID-19 project. Series C financing boosts post-money valuation to RMB4.45...
Xinyao (Criss) Wang
Follow
589 Views
Share
bullish
•
Japan Post Bank
•
03 Mar 2025 07:45
ECM Weekly (3rd Mar 2025) - Japan Post Bank, JX Advance, Mixue, Chifeng, JSW Cement, Premier, Guzman
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
Sumeet Singh
Follow
748 Views
Share
bearish
•
Vigonvita Life Sciences
•
26 Feb 2025 10:27
Vigonvita Life Sciences (旺山旺水) Pre-IPO Tearsheet
Vigonvita seeks US$100M in Hong Kong IPO for COVID-19 drug expansion. It has commercialized COVID-19 drugs in the past and is looking to expand...
Ke Yan, CFA, FRM
Follow
490 Views
Share
Previous
1
2
3
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x